T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastasis|Brain Cancer
Interventions: DRUG: T-DM1|DRUG: TMZ
Sponsor: National Cancer Institute (NCI)